Abstract
Appendiceal adenocarcinomas are uncommon, and the genetic alterations present in these tumors are not well characterized. We studied genetic alterations including loss of chromosome 18q (location of DCC, DPC4, and JV-18 genes), and mutations of the DPC4 (SMAD4) and β-catenin genes in 28 appendiceal adenocarcinomas, consisting of 17 mucinous and 11 nonmucinous carcinomas. Chromosome 18q loss was present in 57% (12/21) of appendiceal carcinomas including 54% (7/13) of mucinous and 63% (5/8) of nonmucinous carcinomas. Mutation of the DPC4 gene was present in 14% (three of 22) of the carcinomas occurring in one tumor with chromosome 18q loss and in two with unassessed chromosome 18q status. β-catenin gene mutation was present in 0% (0 of 25) of the carcinomas. Chromosome 18q loss status was not associated with any clinicopathological features. The presence of chromosome 18q loss and DPC4 mutations in appendiceal adenocarcinomas suggests involvement of DPC4 and nearby genes on chromosome 18q (DCC and/or JV-18) in the pathogenesis of appendiceal adenocarcinomas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bläker H, von Herbay A, Penzel R, Groß S and Otto HF . (2002). Oncogene, 21, 158–164.
Blons H, Laccourreye O, Houllier AM, Carnot F, Brasnu D, Beaune P, Zucman-Rossi J and Laurent-Puig P . (2002). Oncogene, 21, 5016–5023.
Carr NJ, Arends MJ, Deans GT and Sobin LH . (2000). Pathology and Genetics of Tumors of Digestive System: World Health Organization Classification of Tumors, Hamilton SR and Aaltonen LA (eds). IARC Press: Lyon, pp. 94–98.
Dai JL, Turnacioglu KK, Schutte M, Sugar AY and Kern SE . (1998). Cancer Res., 58, 4592–4597.
Devilee P, van Vliet M, Kuipers-Dijkshorn N, Pearson PL and Cornelisse CJ . (1991). Oncogene, 6, 311–315.
Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW and Vogelstein B . (1990). Science, 247, 49–56.
Font A, Abad A, Monzo M, Sanchez JJ, Guillot M, Manzano JL, Pinol M, Ojanguren I and Rosell R . (2001). Dis. Colon Rectum, 44, 549–557.
Fujii H, Inagaki M, Kasai S, Miyokawa N, Tokusashi Y, Gabrielson E and Hruban RH . (1997). Am. J. Pathol., 151, 1447–1454.
Gao X, Honn KV, Grignon D, Sakr W and Chen YQ . (1993). Cancer Res., 53, 2723–2727.
Hahn SA, Bartsch D, Schroers A, Galehdari H, Becker M, Ramaswamy A, Schwarte-Waldhoff I, Maschek H and Schmiegel W . (1998). Cancer Res., 58, 1124–1126.
Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE . (1996). Science, 271, 350–353.
Hohne MW, Halatsch ME, Kahl GF and Weinel RJ . (1992). Cancer Res., 52, 2616–2619.
Hugh TJ, Dillon SA, Taylor BA, Pignatelli M, Poston GJ and Kinsella AR . (1999). Br. J. Cancer, 80, 1046–1051.
Jen J, Kim H, Piantadosi S, Liu ZF, Levitt RC, Sistonen P, Kinzler KW, Vogelstein B and Hamilton SR . (1994). N. Engl. J. Med., 331, 213–221.
Kabbani W, Houlihan PS, Luthra R, Hamilton SR and Rashid A . (2002). Mod. Pathol., 15, 599–605.
Kanazawa T, Watanabe T, Kazama S, Tada T, Kokeketsu S and Nagawa H . (2002). Int. J. Cancer, 102, 225–229.
Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El-Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML, Lushnikova T, Monni O, Pere H, Tapper J, Tarkkanen M, Varis A, Wasenius VM, Wolf M and Zhu Y . (1999). Am. J. Pathol., 155, 683–694.
Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B and Clevers H . (1997). Science, 275, 1752–1753.
Kremmidiotis G, Baker E, Crawford J, Eyre HJ, Nahmias J and Callen DF . (1998). Genomics, 49, 467–471.
Kytölä S, Nord B, Elder EE, Carling T, Kjellman M, Cedermark B, Juhlin C, Hoog A, Isola J and Larsson C . (2002). Genes Chromosomes Cancer, 34, 325–332.
Lanza G, Matteuzzi M, Gafa R, Orvieto E, Maestri I, Santini A and del Senno L . (1998). Int. J. Cancer, 79, 390–395.
Lassus H, Salovaara R, Aaltonen LA and Butzow R . (2001). Am. J. Pathol., 159, 35–42.
Lei J, Zou TT, Shi YQ, Zhou X, Smolonski KN, Yin J, Souza RF, Appel R, Wang S, Cymes K, Chan O, Abraham JM, Harpaz N and Meltzer SJ . (1996). Oncogene, 13, 2459–2462.
Lyss AP . (1988). Semin. Oncol., 15, 129–137.
MacGrogan D, Pegram M, Slamon D and Bookstein R . (1997). Oncogene, 15, 1111–1114.
Massagué J, Blain SW and Lo RS . (2000). Cell, 103, 295–309.
McCusker ME, Cote TR, Clegg LX and Sobin LH . (2002). Cancer, 94, 3307–3312.
Miyaki M, Ijiima T, Konishi M, Sakai K, Ishii A, Yusuno M, Hishima T, Koike M, Shitara N, Iwama T, Utsunomiya J, Kuroki T and Mori T . (1999). Oncogene, 18, 3098–3103.
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW . (1997). Science, 275, 1787–1790.
Moskaluk CA and Kern SE . (1997). Am. J. Pathol., 150, 1547–1552.
Powell SM, Harper JC, Hamilton SR, Robinson CR and Cummings OW . (1997). Cancer Res., 57, 4221–4224.
Rashid A, Gao YT, Bhakta S, Shen MC, Wang BS, Deng J, Fraumeni Jr JF and Hsing AW . (2001). Cancer Res., 61, 3406–3409.
Roth S, Laiho P, Salovaara R, Launonen V and Aaltonen LA . (2000). Br. J. Cancer, 83, 1015–1019.
Salovaara R, Roth S, Loukola A, Launonen V, Sistonen P, Avizienyte E, Kristo P, Järvinen H, Souchelnytskyi S, Sarlomo-Rikala M and Aaltonen LA . (2002). Gut, 51, 56–59.
Schutte M, Hruban RH, Hedrick L, Cho KP, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero Jr RA, Meltzer PS, Hahn SA and Kern SE . (1996). Cancer Res., 56, 2527–2530.
Shi Y and Massagué J . (2003). Cell, 113, 685–700.
Sparks AB, Morin PJ, Vogelstein B and Kinzler KW . (1998). Cancer Res., 58, 1130–1134.
Szyck C, Staebler A, Connolly DC, Wu R, Cho KR and Ronnett BM . (1999). Am. J. Pathol., 154, 1849–1855.
Takagi Y, Kohmura H, Futamura M, Kida H, Tanemura H, Shimokawa K and Saji S . (1996). Gastroentrerology, 111, 1369–1372.
Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Wilson JK, Markovitz S, Hamilton SR, Kern SE, Kinzler KW and Vogelstein B . (1996). Nat. Genet., 13, 343–346.
Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kobayashi M, Sugimura T and Hirohashi Sl . (1992). Cancer Res., 52, 3099–3102.
Zou Z, Anisowicz A, Hendricks MJ, Thor A, Neveu M and Sheng S . (1994). Science, 263, 526–529.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maru, D., Wu, TT., Canada, A. et al. Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas. Oncogene 23, 859–864 (2004). https://doi.org/10.1038/sj.onc.1207194
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207194
Keywords
This article is cited by
-
The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review
Cancer and Metastasis Reviews (2023)
-
Inflammatory bowel disease and carcinogenesis
Cancer and Metastasis Reviews (2022)
-
Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer
British Journal of Cancer (2020)
-
PfSMAD4 plays a role in biomineralization and can transduce bone morphogenetic protein-2 signals in the pearl oyster Pinctada fucata
BMC Developmental Biology (2016)
-
Muzinöse Neoplasien der Appendix vermiformis, Pseudomyxoma peritonei und die neue WHO-Klassifikation
Der Pathologe (2012)